Blend Therapeutics Secures $5,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ea2bb10-ec35-4f9a-9b8c-8328156ceda6
Date
12/26/2013
Company Name
Blend Therapeutics
Mailing Address
134 Coolidge Avenue Watertown, MA 02472
Company Description
Blend is pioneering controlled combination medicines that overcome the limitations of conventional combination therapy through their unprecedented ability to hit distinct disease pathways with multiple drugs in concert—at the desired sites, at the most effective concentrations, and for the right durations—to drive optimal effects from each drug on the disease process.
Website
http://www.blendtx.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed